Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases
- PMID: 10036633
- DOI: 10.3109/08830189809054404
Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases
Abstract
Recent advances in knowledge of crystal structures of MHC class II molecules has advanced understanding of the molecular basis for interactions between peptides and HLA class II molecules. Polymorphism of HLA class II molecules influences structures of peptides bound to HLA class II molecules. To better understand mechanisms related to particular HLA class II alleles and autoimmune diseases, it is important to identify self-peptides presented by disease-susceptible HLA class II molecules and triggering disease-causative autoreactive T cells. Autoimmune diseases occur in Caucasians, Blacks and Asians, albeit with a different incidence. In some autoimmune diseases, disease-susceptible HLA class II alleles are closely related but different, and clinical manifestations of diseases differ among ethnic groups. These phenomena strongly suggest that difference in autoimmune self-peptide(s) in the context of disease-susceptible HLA class II molecules may explain the different clinical manifestations of diseases. Therefore, a comparison among disease-susceptible HLA class II alleles, autoimmune self-peptides and clinical manifestations of autoimmune diseases in different ethnic groups would be instructive. We directed efforts to determining: (1) HLA-class II alleles specific to Asian populations and which are associated with susceptibility to autoimmune diseases, (2) binding-peptide motifs for these HLA class II molecules, and (3) self-peptides presented by susceptible HLA class II molecules to stimulate autoreactive T cells related to the development of autoimmune diseases in Asians. In this review, our related recent investigations are described and the uniqueness of HLA class II-associated autoimmune diseases in Asians is given emphasis.
Similar articles
-
[Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].Nihon Rinsho. 1997 Jun;55(6):1384-96. Nihon Rinsho. 1997. PMID: 9200922 Review. Japanese.
-
Molecular analyses of HLA class II-associated susceptibility to subtypes of autoimmune diseases unique to Asians.Int J Cardiol. 1998 Oct 1;66 Suppl 1:S93-104; discussion S105. doi: 10.1016/s0167-5273(98)00156-9. Int J Cardiol. 1998. PMID: 9951808 Review.
-
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.Mod Rheumatol. 2001 Jun;11(2):103-12. doi: 10.3109/s101650170020. Mod Rheumatol. 2001. PMID: 24383685
-
Molecular aspects of HLA class II and some autoimmune diseases.Eur J Immunogenet. 1993 Jun;20(3):153-64. doi: 10.1111/j.1744-313x.1993.tb00106.x. Eur J Immunogenet. 1993. PMID: 8338813 Review. No abstract available.
-
HLA class II transgenic mice as models of human diseases.Immunol Rev. 1999 Jun;169:67-79. doi: 10.1111/j.1600-065x.1999.tb01307.x. Immunol Rev. 1999. PMID: 10450509 Review.
Cited by
-
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis.Curr Diab Rep. 2016 Jul;16(7):63. doi: 10.1007/s11892-016-0752-4. Curr Diab Rep. 2016. PMID: 27168063 Free PMC article. Review.
-
Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.Clin Vaccine Immunol. 2011 Jun;18(6):990-3. doi: 10.1128/CVI.00073-11. Epub 2011 Apr 13. Clin Vaccine Immunol. 2011. PMID: 21490167 Free PMC article.
-
Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China.Front Immunol. 2023 Jun 9;14:1164120. doi: 10.3389/fimmu.2023.1164120. eCollection 2023. Front Immunol. 2023. PMID: 37359544 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials